The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2017

Filed:

Jun. 27, 2014
Applicant:

Nektar Therapeutics, San Francisco, CA (US);

Inventors:

Neel K. Anand, San Mateo, CA (US);

Franco J. Duarte, Millbrae, CA (US);

Wen Zhang, San Ramon, CA (US);

Zhongxu Ren, Foster City, CA (US);

Assignee:

Nektar Therapeutics, San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/12 (2006.01); C07C 233/05 (2006.01); C07D 207/09 (2006.01); C07D 401/12 (2006.01); C07D 295/125 (2006.01); C07C 233/40 (2006.01); C07C 205/04 (2006.01); C07C 333/00 (2006.01); C07D 241/04 (2006.01); C07D 207/12 (2006.01); C07D 207/14 (2006.01); C07D 213/56 (2006.01); C07D 333/48 (2006.01); C07D 213/61 (2006.01); C07D 205/04 (2006.01);
U.S. Cl.
CPC ...
C07D 409/12 (2013.01); C07C 233/05 (2013.01); C07C 233/40 (2013.01); C07D 205/04 (2013.01); C07D 207/09 (2013.01); C07D 207/12 (2013.01); C07D 207/14 (2013.01); C07D 213/56 (2013.01); C07D 213/61 (2013.01); C07D 241/04 (2013.01); C07D 295/125 (2013.01); C07D 333/48 (2013.01); C07D 401/12 (2013.01);
Abstract

Provided are compounds of Formula I; and pharmaceutically acceptable salts and solvates thereof. The present disclosure relates to novel compounds and to their use as agonists of the kappa opioid receptor. The disclosure also relates to methods for preparation of the compounds and to pharmaceutical compositions containing such compounds. Kappa opioid agonists that exhibit full agonist properties at the kappa opioid receptor have been widely shown to be efficacious in preclinical models of pain, particularly visceral pain.


Find Patent Forward Citations

Loading…